95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.94%
Revenue growth at 75-90% of FSM's 2.29%. Bill Ackman would push for innovation or market expansion to catch up.
3.70%
Positive gross profit growth while FSM is negative. John Neff would see a clear operational edge over the competitor.
-0.01%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.01%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
2.54%
Positive net income growth while FSM is negative. John Neff might see a big relative performance advantage.
2.78%
Positive EPS growth while FSM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
2.78%
Positive diluted EPS growth while FSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.13%
Share reduction more than 1.5x FSM's 0.51%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.13%
Diluted share reduction more than 1.5x FSM's 0.48%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-6.78%
Negative OCF growth while FSM is at 39.79%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
97.38%
FCF growth 75-90% of FSM's 122.92%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
33.15%
10Y revenue/share CAGR under 50% of FSM's 229.79%. Michael Burry would suspect a lasting competitive disadvantage.
50.97%
5Y revenue/share CAGR at 50-75% of FSM's 90.85%. Martin Whitman would worry about a lagging mid-term growth trajectory.
53.17%
3Y revenue/share CAGR 1.25-1.5x FSM's 41.01%. Bruce Berkowitz might see better product or regional expansions than the competitor.
0.93%
10Y OCF/share CAGR under 50% of FSM's 70.40%. Michael Burry would worry about a persistent underperformance in cash creation.
56.40%
Below 50% of FSM's 1672.65%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
57.62%
3Y OCF/share CAGR above 1.5x FSM's 16.35%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-11.94%
Negative 10Y net income/share CAGR while FSM is at 73.33%. Joel Greenblatt sees a major red flag in long-term profit erosion.
167.29%
Below 50% of FSM's 914.45%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-48.58%
Negative 3Y CAGR while FSM is 25.07%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
90.57%
10Y equity/share CAGR at 50-75% of FSM's 136.70%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
19.17%
Below 50% of FSM's 101.66%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
11.80%
3Y equity/share CAGR similar to FSM's 12.33%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
666.81%
Dividend/share CAGR of 666.81% while FSM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
173.48%
Dividend/share CAGR of 173.48% while FSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
57.86%
3Y dividend/share CAGR of 57.86% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
139.98%
Our AR growth while FSM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-1.95%
Inventory is declining while FSM stands at 4.40%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.89%
Asset growth at 50-75% of FSM's 1.32%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
1.93%
Similar to FSM's 1.82%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-4.69%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
68.08%
SG&A growth well above FSM's 6.82%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.